Cancer Research; Cell Biology; Cellular and Molecular Neuroscience; Immunology
Abstract :
[en] Wolfram syndrome (WS) is a rare neurodegenerative disorder encompassing diabetes mellitus, diabetes insipidus, optic atrophy, hearing loss (HL) as well as neurological disorders. None of the animal models of the pathology are presenting with an early onset HL, impeding the understanding of the role of Wolframin (WFS1), the protein responsible for WS, in the auditory pathway. We generated a knock-in mouse, the Wfs1E864K line, presenting a human mutation leading to severe deafness in affected individuals. The homozygous mice showed a profound post-natal HL and vestibular syndrome, a collapse of the endocochlear potential (EP) and a devastating alteration of the stria vascularis and neurosensory epithelium. The mutant protein prevented the localization to the cell surface of the Na+/K+ATPase β1 subunit, a key protein for the maintenance of the EP. Overall, our data support a key role of WFS1 in the maintenance of the EP and the stria vascularis, via its binding partner, the Na+/K+ATPase β1 subunit.
Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet. 1995;346:1458–63.
Bespalova IN, Van Camp G, Bom SJ, Brown DJ, Cryns K, DeWan AT, et al. Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum Mol Genet. 2001;10:2501–8.
Lesperance MM, Hall JW, San Agustin TB, Leal SM. Mutations in the Wolfram syndrome type 1 gene (WFS1) define a clinical entity of dominant low-frequency sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 2003;129:411–20.
Eiberg H, Hansen L, Kjer B, Hansen T, Pedersen O, Bille M, et al. Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene. J Med Genet. 2006;43:435–40.
Valéro R, Bannwarth S, Roman S, Paquis-Flucklinger V, Vialettes B. Autosomal dominant transmission of diabetes and congenital hearing impairment secondary to a missense mutation in the WFS1 gene. Diabet Med. 2008;25:657–61.
De Franco E, Flanagan SE, Yagi T, Abreu D, Mahadevan J, Johnson MB, et al. Dominant ER stress-inducing WFS1 mutations underlie a genetic syndrome of neonatal/infancy-onset diabetes, congenital sensorineural deafness, and congenital cataracts. Diabetes. 2017;66:2044–53.
Tranebjærg L, Barrett T, Rendtorff ND. WFS1 wolfram syndrome spectrum disorder. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, et al., editors. GeneReviews®. Seattle (WA): University of Washington; 1993.
Grenier J, Meunier I, Daien V, Baudoin C, Halloy F, Bocquet B, et al. WFS1 in optic neuropathies: mutation findings in nonsyndromic optic atrophy and assessment of clinical severity. Ophthalmology. 2016;123:1989–98.
Hilson JB, Merchant SN, Adams JC, Joseph JT. Wolfram syndrome: a clinicopathologic correlation. Acta Neuropathol. 2009;118:415–28.
Cryns K, Thys S, Van Laer L, Oka Y, Pfister M, Van Nassauw L, et al. The WFS1 gene, responsible for low frequency sensorineural hearing loss and Wolfram syndrome, is expressed in a variety of inner ear cells. Histochem Cell Biol. 2003;119:247–56.
Suzuki N, Hosoya M, Oishi N, Okano H, Fujioka M, Ogawa K. Expression pattern of wolframin, the WFS1 (Wolfram syndrome-1 gene) product, in common marmoset (Callithrix jacchus) cochlea. Neuroreport. 2016;27:833–6.
Angebault C, Fauconnier J, Patergnani S, Rieusset J, Danese A, Affortit CA, et al. ER-mitochondria cross-talk is regulated by the Ca2+ sensor NCS1 and is impaired in Wolfram syndrome. Sci Signal. 2018;11. 10.1126/scisignal.aaq1380.
Loncke J, Vervliet T, Parys JB, Kaasik A, Bultynck G. Uniting the divergent Wolfram syndrome-linked proteins WFS1 and CISD2 as modulators of Ca2+ signaling. Sci Signal. 2021;14:eabc6165.
Loncke J, Kaasik A, Bezprozvanny I, Parys JB, Kerkhofs M, Bultynck G. Balancing ER-mitochondrial Ca2+ fluxes in health and disease. Trends Cell Biol. 2021;31:598–612.
Crouzier L, Danese A, Yasui Y, Richard EM, Liévens J-C, Patergnani S, et al. Activation of the sigma-1 receptor chaperone alleviates symptoms of Wolfram syndrome in preclinical models. Sci Transl Med. 2022;14:eabh3763.
Zatyka M, Ricketts C, da Silva Xavier G, Minton JA, Fenton S, Hofmann-Thiel S, et al. Sodium-potassium ATPase beta 1 subunit is a molecular partner of Wolframin, an endoplasmic reticulum (ER) protein involved in ER stress. Hum Mol Genet. 2008;17:190–200.
Geering K. Functional roles of Na,K-ATPase subunits. Curr Opin Nephrol Hypertens. 2008;17:526–32.
Clausen MV, Hilbers F, Poulsen H. The structure and function of the Na,K-ATPase isoforms in health and disease. Front Physiol. 2017;8:371.
Liu W, Rask-Andersen H. Na/K-ATPase gene expression in the human cochlea: a study using mRNA in situ hybridization and super-resolution structured illumination microscopy. Front Mol Neurosci. 2022;15:857216.
Liu W, Luque M, Glueckert R, Danckwardt-Lillieström N, Nordström CK, Schrott-Fischer A, et al. Expression of Na/K-ATPase subunits in the human cochlea: a confocal and super-resolution microscopy study with special reference to auditory nerve excitation and cochlear implantation. Upsala J Med Sci. 2019;124:168–79.
Schulte BA, Steel KP. Expression of alpha and beta subunit isoforms of Na,K-ATPase in the mouse inner ear and changes with mutations at the Wv or Sld loci. Hear Res. 1994;78:65–76.
Erichsen S, Zuo J, Curtis L, Rarey K, Hultcrantz M. Na,K-ATPase alpha- and beta-isoforms in the developing cochlea of the mouse. Hear Res. 1996;100:143–9.
Plaas M, Seppa K, Reimets R, Jagomäe T, Toots M, Koppel T, et al. Wfs1-deficient rats develop primary symptoms of Wolfram syndrome: insulin-dependent diabetes, optic nerve atrophy and medullary degeneration. Sci Rep. 2017;7:10220.
Jagomäe T, Seppa K, Reimets R, Pastak M, Plaas M, Hickey MA, et al. Early intervention and lifelong treatment with GLP1 receptor agonist liraglutide in a Wolfram syndrome rat model with an emphasis on visual neurodegeneration, sensorineural hearing loss and diabetic phenotype. Cells. 2021;10:3193.
Cairns G, Burté F, Price R, O’Connor E, Toms M, Mishra R, et al. A mutant wfs1 zebrafish model of Wolfram syndrome manifesting visual dysfunction and developmental delay. Sci Rep. 2021;11:20491.
Crouzier L, Richard EM, Diez C, Alzaeem H, Denus M, Cubedo N, et al. Morphological, behavioral and cellular analyses revealed different phenotypes in Wolfram syndrome wfs1a and wfs1b zebrafish mutant lines. Hum Mol Genet. 2022;31:2711–27.
Ishihara H, Takeda S, Tamura A, Takahashi R, Yamaguchi S, Takei D, et al. Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet. 2004;13:1159–70.
Luuk H, Plaas M, Raud S, Innos J, Sütt S, Lasner H, et al. Wfs1-deficient mice display impaired behavioural adaptation in stressful environment. Behav Brain Res. 2009;198:334–45.
Fukuoka H, Kanda Y, Ohta S, Usami S-I. Mutations in the WFS1 gene are a frequent cause of autosomal dominant nonsyndromic low-frequency hearing loss in Japanese. J Hum Genet. 2007;52:510–5.
Kobayashi M, Miyagawa M, Nishio S-Y, Moteki H, Fujikawa T, Ohyama K, et al. WFS1 mutation screening in a large series of Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis. PLoS ONE. 2018;13:e0193359.
Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. J Pharmacol Pharmacother. 2010;1:94–99.
Affortit C, Casas F, Ladrech S, Ceccato J-C, Bourien J, Coyat C, et al. Exacerbated age-related hearing loss in mice lacking the p43 mitochondrial T3 receptor. BMC Biol. 2021;19:18.
Brugeaud A, Travo C, Demêmes D, Lenoir M, Llorens J, Puel J-L, et al. Control of hair cell excitability by vestibular primary sensory neurons. J Neurosci. 2007;27:3503–11.
Fasquelle L, Scott HS, Lenoir M, Wang J, Rebillard G, Gaboyard S, et al. Tmprss3, a transmembrane serine protease deficient in human DFNB8/10 deafness, is critical for cochlear hair cell survival at the onset of hearing. J Biol Chem. 2011;286:17383–97.
Ladrech S, Wang J, Simonneau L, Puel J-L, Lenoir M. Macrophage contribution to the response of the rat organ of Corti to amikacin. J Neurosci Res. 2007;85:1970–9.
Liu J, Periyasamy SM, Gunning W, Fedorova OV, Bagrov AY, Malhotra D, et al. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells. Kidney Int. 2002;62:2118–25.
Møller AR, Jannetta PJ, Sekhar LN. Contributions from the auditory nerve to the brain-stem auditory evoked potentials (BAEPs): results of intracranial recording in man. Electroencephalogr Clin Neurophysiol. 1988;71:198–211.
Geering K. The functional role of the beta-subunit in the maturation and intracellular transport of Na,K-ATPase. FEBS Lett. 1991;285:189–93.
Wolfram DJ, Wagner HP. Diabetes mellitus and simple optic atrophy among siblings. Mayo Clin Proc. 1938;13:715–8.
Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, Bernal-Mizrachi E, et al. A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet. 1998;20:143–8.
Urano F. Wolfram syndrome: diagnosis, management, and treatment. Curr Diab Rep. 2016;16:6.
Rigoli L, Caruso V, Salzano G, Lombardo F. Wolfram syndrome 1: from genetics to therapy. Int J Environ Res Public Health. 2022;19:3225.
Crouzier L, Richard EM, Diez C, Denus M, Peyrel A, Alzaeem H, et al. NCS1 overexpression restored mitochondrial activity and behavioral alterations in a zebrafish model of Wolfram syndrome. Mol Ther Methods Clin Dev. 2022;27:295–308.
Higashi K. Otologic findings of DIDMOAD syndrome. Am J Otol. 1991;12:57–60.
Cremers CW, Wijdeveld PG, Pinckers AJ. Juvenile diabetes mellitus, optic atrophy, hearing loss, diabetes insipidus, atonia of the urinary tract and bladder, and other abnormalities (Wolfram syndrome). A review of 88 cases from the literature with personal observations on 3 new patients. Acta Paediatr Scand Suppl. 1977;264:1–16.
Megighian D, Savastano M. Wolfram syndrome. Int J Pediatr Otorhinolaryngol. 2004;68:243–7.
Barjon P, Lestradet H, Labauge R. Primary optic atrophy and neurogenic deafness in juvenile diabetes (apropos of 3 cases). Presse Med. 1964;72:983–6.
Pennings RJE, Huygen PLM, van den Ouweland JMW, Cryns K, Dikkeschei LD, Van Camp G, et al. Sex-related hearing impairment in Wolfram syndrome patients identified by inactivating WFS1 mutations. Audiol Neurootol. 2004;9:51–62.
Karzon RK, Hullar TE. Audiologic and vestibular findings in Wolfram syndrome. Ear Hear. 2013;34:809–12.
Rigoli L, Bramanti P, Di Bella C, De, Luca F. Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease. Pediatr Res. 2018;83:921–9.
de Heredia ML, Clèries R, Nunes V. Genotypic classification of patients with Wolfram syndrome: insights into the natural history of the disease and correlation with phenotype. Genet Med. 2013;15:497–506.
Delvecchio M, Iacoviello M, Pantaleo A, Resta N. Clinical spectrum associated with Wolfram syndrome type 1 and type 2: a review on genotype-phenotype correlations. Int J Environ Res Public Health. 2021;18:4796.
Carignano C, Barila EP, Rías EI, Dionisio L, Aztiria E, Spitzmaul G. Inner hair cell and neuron degeneration contribute to hearing loss in a DFNA2-like mouse model. Neuroscience. 2019;410:202–16.
Wangemann P. Supporting sensory transduction: cochlear fluid homeostasis and the endocochlear potential. J Physiol. 2006;576:11–21.
Wangemann P. K+ cycling and the endocochlear potential. Hearing Res. 2002;165:1–9.
Wangemann P. Potassium ion secretion and generation of the endocochlear potential in the stria vascularis. HNO. 1997;45:205–9.
Nin F, Hibino H, Doi K, Suzuki T, Hisa Y, Kurachi Y. The endocochlear potential depends on two K+ diffusion potentials and an electrical barrier in the stria vascularis of the inner ear. Proc Natl Acad Sci USA. 2008;105:1751–6.
Nin F, Yoshida T, Sawamura S, Ogata G, Ota T, Higuchi T, et al. The unique electrical properties in an extracellular fluid of the mammalian cochlea; their functional roles, homeostatic processes, and pathological significance. Pflugers Arch. 2016;468:1637–49.
Lee MP, Ravenel JD, Hu RJ, Lustig LR, Tomaselli G, Berger RD, et al. Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. J Clin Invest. 2000;106:1447–55.
Vetter DE, Mann JR, Wangemann P, Liu J, McLaughlin KJ, Lesage F, et al. Inner ear defects induced by null mutationof the isk Gene. Neuron. 1996;17:1251–64.
Rozengurt N, Lopez I, Chiu C-S, Kofuji P, Lester HA, Neusch C. Time course of inner ear degeneration and deafness in mice lacking the Kir4.1 potassium channel subunit. Hear Res. 2003;177:71–80.
Hibino H, Nin F, Tsuzuki C, Kurachi Y. How is the highly positive endocochlear potential formed? The specific architecture of the stria vascularis and the roles of the ion-transport apparatus. Pflugers Arch. 2010;459:521–33.
Chen J, Zhao H-B. The role of an inwardly rectifying K(+) channel (Kir4.1) in the inner ear and hearing loss. Neuroscience. 2014;265:137–46.
Kusakari J, Ise I, Comegys TH, Thalmann I, Thalmann R. Effect of ethacrynic acid, furosemide, and ouabain upon the endolymphatic potential and upon high energy phosphates of the stria vascularis. Laryngoscope. 1978;88:12–37.
Delprat B, Schaer D, Roy S, Wang J, Puel J-L, Geering K. FXYD6 is a novel regulator of Na,K-ATPase expressed in the inner ear. J Biol Chem. 2007;282:7450–6.
Ding B, Walton JP, Zhu X, Frisina RD. Age-related changes in Na, K-ATPase expression, subunit isoform selection and assembly in the stria vascularis lateral wall of mouse cochlea. Hear Res. 2018;367:59–73.
Korrapati S, Taukulis I, Olszewski R, Pyle M, Gu S, Singh R, et al. Single cell and single nucleus RNA-Seq reveal cellular heterogeneity and homeostatic regulatory networks in adult mouse stria vascularis. Front Mol Neurosci. 2019;12:316.
Kryvenko V, Vagin O, Dada LA, Sznajder JI, Vadász I. Maturation of the Na,K-ATPase in the endoplasmic reticulum in health and disease. J Membrane Biol. 2021;254:447–57.
Bartolami S, Gaboyard S, Quentin J, Travo C, Cavalier M, Barhanin J, et al. Critical roles of transitional cells and Na/K-ATPase in the formation of vestibular endolymph. J Neurosci. 2011;31:16541–9.
